Retired and Emeritus Faculty

The Department of Microbiology & Immunology faculty have made outstanding contributions to biology and medicine since the department was founded in 1893. Past faculty member Sherie Morrison discovered the technology of chimeric antibodies which is used in the development of drugs such as Erbitux and Remicade that have revolutionized treatment of cancer and inflammatory diseases and emeritus faculty member and former chair Saul Silverstein, in collaboration with Michael Wigler and Nobel Prize winner Richard Axel, helped discover the co-transformation process used to develop important drugs, such as tissue plasminogen activator (TPA), beta interferon and erythropoietin (EPO).